BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

B7 H1 Antigen

An inhibitory B7 antigen that contains V-type and C2 type immunoglobulin domains. It has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN and provides negative signals that control and inhibit T-cell responses. It is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.

53+ PubMed studies analyzed · Evidence Score: 47.8

Research Domains

B7 H1 Antigen has been studied across 11 research domains including 🔬 Oncology, 🛡️ Immunity, ✨ Skin & Hair, 🔬 Inflammation, ⏳ Longevity & Aging. The primary research focus is 🔬 Oncology with 83% of studies addressing this area.

Loading evidence profile...

This evidence profile for B7 H1 Antigen is generated deterministically from 53 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.